13568_2020_1051_MOESM3_ESM.tiff (2.69 MB)
Additional file 3 of Recombinant tandem epitope vaccination provides cross protection against Actinobacillus pleuropneumoniae challenge in mice
figure
posted on 2020-07-09, 05:25 authored by Jiameng Xiao, Jianfang Liu, Chuntong Bao, Rining Zhu, Jingmin Gu, Changjiang Sun, Xin Feng, Chongtao Du, Wenyu Han, Yang Li, Liancheng LeiAdditional file 3: (A), (B), (C) The survival rates of the mice immunized with PBS, RTA protein, inactivated APP1 alone, inactivated APP5b alone, and RTA protein plus inactivated APP at 0, 14, and 28 d and challenged with APP1 and APP5b separately at 35 d. The mice were observed for 3 d to record the survival rates.
